About
Stephen Ting is an Adjunct Clinical Associate Professor at Monash University's Eastern Health Clinical School, specializing in Haematology. He is a clinician-scientist actively practicing as a consultant haematologist at Alfred Hospital and Cabrini Hospital. His research focuses on understanding molecular mechanisms governing haematopoietic and leukemia stem cell self-renewal, with significant contributions to studies on asymmetric cell division (ACD) and HSC expansion. Dr. Ting has received numerous awards, including the Victorian Premier's Award in Medical Research (2005) and NHMRC CJ Martin Fellowship. He leads projects such as the DIAAMOND registry for aplastic anaemia and contributes to initiatives like the PIRATE trial, aiming to improve outcomes for blood cancer patients through prehabilitation.
Education: Completed medical training in clinical and laboratory haematology at Monash University (1998). PhD studies under Prof. Stephen Jane (2000-2005) led to discoveries of the Grhl3 gene. Postdoctoral training at Hopital Cochin (Paris), Montreal (under Prof. Guy Sauvageau), and further research at Peter MacCallum Cancer Centre.
Research Interests: Investigating ACD in HSCs, mitotic spindle dynamics, cytoskeleton genes (e.g., Kif3), and ex-vivo HSC expansion for transplantation. His work bridges clinical practice and research, addressing blood cancers and stem cell therapies.
Grants & Awards: Over $1.5M funding from NHMRC, Cancer Council Victoria, Leukaemia Foundation, and RACP. Published in high-impact journals like Science, Nature Medicine, and Cell Stem Cell.
Teaching: Lecturer in Human Pathology and Clinical Science courses at Monash University. Community service includes speaking at Leukaemia Foundation patient symposiums and volunteer work in Thailand-Myanmar border clinics (1994).
Collaborations: Active in national and international projects, including MRD monitoring for acute myeloid leukaemia and epigenetic studies in myelodysplastic syndromes.
